Acthera Therapeutics
About:
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Website: https://acthera-therapeutics.com/
Top Investors: IMD Startup Competition
Description:
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Total Funding Amount:
7.6M CHF
Headquarters Location:
Basel, Basel-Stadt, Switzerland
Founded Date:
2019-10-01
Contact Email:
info(AT)actheratx.com
Founders:
Andreas Zumbühl, Carlo Bertozzi, Cyrille Maugeais, Pierre-Alain Monnard, Roger Meier
Number of Employees:
1-10
Last Funding Date:
2022-12-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai